2015 Approvals Herald Rapid Progress, Growing Diversity in Precision Medicine

2020-10-06T03:32:57-05:00

The Personalized Medicine Coalition (PMC) reports that 13 of 45 new molecular entities or therapeutic biologics approved by FDA in 2015, or 28%, were personalized medicines. The number of approved personalized (precision) medicines increased from 9 in 2014. While completing the transition to precision medicine will take years and require addressing major challenges, the momentum [...]

2015 Approvals Herald Rapid Progress, Growing Diversity in Precision Medicine2020-10-06T03:32:57-05:00

Mitigating Risk in Neurosciences Studies with e-Source Assessments

2020-10-13T16:00:28-05:00

The case for electronic data capture in neurosciences studies is strong. The high failure rate in CNS development, headlined by a series of failed Alzheimer’s studies, is one reason to seek better methods. According to a Scientific American article by Kenneth Kaitin and Christopher Milne of the Tufts Center for the Study of Drug Development, [...]

Mitigating Risk in Neurosciences Studies with e-Source Assessments2020-10-13T16:00:28-05:00
Go to Top